Segmentation by type categorises Bone Block Fixation Sets into Autograft, Allograft, Synthetic, and Hybrid systems. Autograft sets, which incorporate patient‑derived bone harvested intra‑operatively, command a premium price point and are preferred in procedures demanding maximal biological compatibility; they represent roughly 30 % of the market, constrained by donor site morbidity and limited availability. Allograft fixation sets, using donor‑derived bone processed for safety, hold the largest share at about 35 %, supported by extensive tissue‑bank networks and consistent supply chains. Synthetic systems, composed of bio‑resorbable polymers or ceramic composites, account for 20 % of sales, reflecting growing clinician confidence in engineered scaffolds and regulatory approvals. Hybrid sets combine allograft or autograft bone with synthetic carriers to optimise mechanical strength and osteoinductive potential, contributing the remaining 15 % of market value. This type‑based taxonomy clarifies cost structures, adoption barriers, and growth vectors within the Bone Block Fixation Sets market.